Assignee
APOGENIX GMBH
DE12 patents
Top patents by PatentIndex Score
US9359420B2Jun 7, 2016
Single chain trail fusion polypeptides and encoding nucleic acids
APOGENIX GMBH66 citations98
US9340599B2May 17, 2016
Single chain CD40L fusion polypeptides
APOGENIX GMBH69 citations98
US8921519B2Dec 30, 2014
Single chain fusion polypeptides comprising soluble light cytokine domains
APOGENIX GMBH75 citations98
US8383774B2Feb 26, 2013
Collectin fusion proteins comprising TNF or trail
APOGENIX GMBH12 citations91
US8007813B2Aug 30, 2011
CD95-Fc fusion proteins
APOGENIX GMBH11 citations81
US9212211B2Dec 15, 2015
Trail collectin fusion proteins
APOGENIX GMBH3 citations72
US9527897B2Dec 27, 2016
CD40L collectin fusion proteins and encoding nucleic acid molecules
APOGENIX GMBH1 citations61
US8907063B2Dec 9, 2014
TNF superfamily collectin fusion proteins and encoding nucleic acids
APOGENIX GMBH2 citations61
US9434783B2Sep 6, 2016
Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof
APOGENIX GMBH0 citations52
US9315570B2Apr 19, 2016
Composition comprising a mixture of CD95-Fc isoforms and methods of producing same
APOGENIX GMBH0 citations52
US9469681B2Oct 18, 2016
Fusion proteins forming trimers
APOGENIX GMBH0 citations50
US9540431B2Jan 10, 2017
Inhibitors of the CD95 signaling pathway for treatment of MDS
APOGENIX GMBH0 citations46